AIM 01Investigate the stability of gut microbiota in individuals with inflammatory bowel disease over five years.
AIM 02Identify colitogenic and colitoprotective strains using gnotobiotic mouse models.
AIM 03Assess the implications of strain loss after fecal microbiota transplantation for long-term disease relapse.